[1]黄汕梅,李畅,马梓珊,等.硝石雄黄散治疗冠状动脉粥样硬化性心脏病的应用前景[J].西部中医药,2026,39(02):101-105.[doi:10.12174/j.issn.2096-9600.2026.02.20]
 HUANG Shanmei,LI Chang,MA Zishan,et al.Application Prospect of Xiaoshi Xionghuang Powder in Treating Coronary Atherosclerotic Heart Disease[J].Western Journal of Traditional Chinese Medicine,2026,39(02):101-105.[doi:10.12174/j.issn.2096-9600.2026.02.20]
点击复制

硝石雄黄散治疗冠状动脉粥样硬化性心脏病的应用前景()

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
39
期数:
2026年02期
页码:
101-105
栏目:
研究进展
出版日期:
2026-02-15

文章信息/Info

Title:
Application Prospect of Xiaoshi Xionghuang Powder in Treating Coronary Atherosclerotic Heart Disease
作者:
黄汕梅1, 李畅1, 马梓珊1, 赵洋洋1, 郭玉洪1, 唐陆鸿1, 柳伟文1, 刘鹰1,2, 唐耀平1,2
1.广西中医药大学附属瑞康医院,广西 南宁 530011
2.广西中医药大学,广西 南宁 530200
Author(s):
HUANG Shanmei1, LI Chang1, MA Zishan1, ZHAO Yangyang1, GUO Yuhong1, TANG Luhong1, LIU Weiwen1, LIU Ying1,2, TANG Yaoping1,2
1.Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, China
2.Guangxi University of Chinese Medicine, Nanning 530200, China
关键词:
冠状动脉粥样硬化性心脏病炎症因子硝石雄黄散硝酸盐亚硝酸盐一氧化氮
Keywords:
coronary atherosclerotic heart diseaseinflammatory factorpowdernitratenitritenitric oxide
分类号:
R259
DOI:
10.12174/j.issn.2096-9600.2026.02.20
文献标志码:
A
摘要:
对硝石雄黄散防治冠状动脉粥样硬化性心脏病(coronary artery diseases,CAD)的应用前景进行探讨,指出炎症因子、氧化应激反应及体内一氧化氮(nitric oxide,NO)水平与CAD的形成和发展密切相关;硝石雄黄散是基于“心开窍于舌”理论治疗CAD的传统古方,其中,雄黄通过抑制炎症因子表达和超氧化物生成来发挥抗炎和抗氧化作用,而硝石作为一种NO3-可以从体外途径(NO3--NO2--NO途径)补充,产生大量的NO活性物质,使血管舒张,并进一步抑制炎症因子与血小板在血管内皮的黏附聚集;硝石和雄黄配伍使用,不仅可以迅速提高体内NO水平,还可以增强硝石雄黄散缓解体内氧化应激反应和炎性反应的作用,这可能是硝石雄黄散治疗CAD的潜在作用机制。
Abstract:
By discussing the application prospects of Xiaoshi (saltpeter) Xionghuang (realgar) powder in the prevention and treatment of coronary atherosclerotic heart disease (CAD), inflammatory factor, oxidative stress response and the levels of NO in vivo are closely related to the formation of CAD; Xiaoshi Xionghuang powder is one of the traditional ancient prescriptions for the treatment of CAD based on the theory of "the heart opens into the tongue", among them, Xionghuang could exert anti-inflammatory and antioxidant effects by restraining the expressions of inflammatory factor and inhibiting superoxide generation, while Xiaoshi as a NO3-, could be supplemented from extrinsic pathway (NO3--NO2--NO pathway), generating a large amount of NO active substances, inducing vasodilation, and further inhibiting adhesion-aggregation of inflammatory factors and platelet in vascular endothelium; the compatibility of Xiaoshi and Xionghuang, could not only rapidly increase the levels of NO in the body, but also enhance the effects of the powder in alleviating oxidative stress and inflammatory responses in the body, which might explain the potential mechanism of the powder in the treatment of CAD.

相似文献/References:

[1]郑光敏,庞菲,张威,等.参芪汤在冠状动脉粥样硬化性心脏病综合康复治疗中的作用[J].西部中医药,2014,27(09):102.
[2]吴志科.中西药物联合治疗术后炎性肠梗阻40例[J].西部中医药,2013,26(09):10.
 WU Zhike.Treatment for 40 Cases of Postoperative Inflammatory Ileus with Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(02):10.
[3]燕忠生,魏千程,李俊,等.三种不同功效中药注射制剂治疗放射性肺炎的实验研究[J].西部中医药,2014,27(03):36.
 YAN Zhongsheng,WEI Qiancheng,LI Jun,et al.Experimental Study on Treating Radiation Pneumonitis by Three Kinds of Different Herbal Injections[J].Western Journal of Traditional Chinese Medicine,2014,27(02):36.
[4]张永科,马天寿.小柴胡汤联合多靶点激素治疗肾病综合征60例[J].西部中医药,2014,27(10):120.
[5]顾志燕,王永.参麦联合环磷腺苷葡胺治疗冠心病心力衰竭临床观察[J].西部中医药,2014,27(11):112.
[6]写国斌,展存丽,张军.眩晕康汤联合倍他司汀治疗无痛性心绞痛99例[J].西部中医药,2016,29(02):110.
 XIE Guobin,ZHAN Cunli,ZHANG Jun.XuanYun Kang Decoction Combined with Betahistine in Treating 99 Cases of Stable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2016,29(02):110.
[7]解鑫隆,徐朝军△,尹晓清,等.醒脑静辅助奥氮平治疗主动脉夹层腔内隔绝术后谵妄45例[J].西部中医药,2018,31(10):79.
 XIE Xinlong,XU Chaojun,YIN Xiaoqing,et al.Treating 45 Cases of Delirium after the EVGE for Aortic Dissection by XingNaoJing Injection as AT and Olanzapine[J].Western Journal of Traditional Chinese Medicine,2018,31(02):79.
[8]邢艳梅.妇炎宁汤联合抗生素治疗慢性盆腔炎52例[J].西部中医药,2018,31(10):97.
 XING Yanmei.FuYanNing Decoction and Antibiotics in Treating 52 Cases of Chronic Pelvic Inflammation[J].Western Journal of Traditional Chinese Medicine,2018,31(02):97.
[9]余新华,郑汉印,徐丽.透明质酸钠联合六味地黄丸治疗老年膝骨性关节炎50例[J].西部中医药,2017,30(08):120.
 YU Xinhua,ZHENG Hanyin,XU Li.Sodium Hyaluronate Combined with LiuWei DiHuang Pills in Treating 50 Senile Patients with Knee Osteoarthritis[J].Western Journal of Traditional Chinese Medicine,2017,30(02):120.
[10]张靓,赵雷,孙芳园,等.升降散治疗瘀毒内阻型脓毒症的临床研究[J].西部中医药,2017,30(12):45.
 ZHANG Liang,ZHAO Lei,SUN Fangyuan,et al.Clinical Study of ShengJiang Powder in the Treatment of Sepsis of Stasis-Toxin Internal Obstruction Pattern[J].Western Journal of Traditional Chinese Medicine,2017,30(02):45.

备注/Memo

备注/Memo:
国家自然科学基金(81460721,81774115);广西中医药大学研究生教育创新计划项目(xjyb098)。黄汕梅(1996—),女,硕士学位。研究方向:中西医结合防治心血管疾病。
更新日期/Last Update: 2026-02-15